Blockade of CCR5 to protect the liver graft in HIV/HCV co-infected patients.
Haïm-Boukobza, Stéphanie
Blockade of CCR5 to protect the liver graft in HIV/HCV co-infected patients. [electronic resource] - Journal of hepatology Sep 2013 - 613-5 p. digital
Publication Type: Journal Article; Comment
1600-0641
10.1016/j.jhep.2013.03.034 doi
CCR5 Receptor Antagonists
Chemotaxis, Leukocyte--drug effects
Cyclohexanes--therapeutic use
Female
Graft vs Host Disease--prevention & control
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Male
T-Lymphocytes--drug effects
Triazoles--therapeutic use
Blockade of CCR5 to protect the liver graft in HIV/HCV co-infected patients. [electronic resource] - Journal of hepatology Sep 2013 - 613-5 p. digital
Publication Type: Journal Article; Comment
1600-0641
10.1016/j.jhep.2013.03.034 doi
CCR5 Receptor Antagonists
Chemotaxis, Leukocyte--drug effects
Cyclohexanes--therapeutic use
Female
Graft vs Host Disease--prevention & control
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Male
T-Lymphocytes--drug effects
Triazoles--therapeutic use